Practice Areas - Debt Capital Markets Law Firms and Lawyers
| Deal Date: | 03-11-2014 | Practice Area: | Debt Capital Markets |
| Deal Title: | Synergy Pharmaceuticals Convertible Senior Notes due 2019 | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk acted as special product counsel for Merrill Lynch, Pierce, Fenner and Smith Incorporated as representative of the initial purchasers in connection with a Rule 144A offering by Synergy Pharmaceuticals Inc. of an aggregate principal amount of USD200 million of 7.5% convertible senior notes due 2019, which included USD25 million aggregate principal amount of convertible senior notes issued pursuant to the exercise in full of the initial purchasers' over-allotment option.
The Davis Polk equity derivatives team included partners John M. Brandow and Ray Ibrahim and associates Barry J. Gewolb and Erica B. Richey.
|
||
| Financial Center: | New York | Value: | 100.01-500.00 |
| Advised Party: | Underwriter | Law Firm | Davis Polk |
| Issuer Jurisdiction: | United States | Listing Jurisdiction: | United States |
| Classification: |
Equity-Linked Securities Convertible Bonds |
Lawyer | John M Brandow |
